Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N) (WKN: A422EZ) announced it has entered into a non-binding letter of intent to explore the acquisition of Vancouver-based Quantum.IQ, an AI-driven quantum cybersecurity company focused on helping organizations prepare for emerging quantum-enabled cyber threats. Quantum.IQ’s post-quantum cryptography platform is designed to assist government, defense, financial services and critical infrastructure organizations in assessing cryptographic vulnerabilities, planning migration to quantum-resistant security systems and monitoring ongoing cybersecurity readiness.
Under the proposed transaction, Redwood would acquire all outstanding shares of Quantum.IQ in exchange for up to 14 million Redwood common shares, including milestone-based consideration, with all shares subject to a staged escrow release schedule over 24 months. The acquisition remains subject to due diligence, definitive agreements, regulatory approvals and other customary closing conditions. Redwood said the addition of Quantum.IQ could expand its capabilities in cryptographic intelligence, quantum-readiness assessment and cybersecurity planning, complementing its broader focus on artificial intelligence and advanced computational technologies.
This move is significant as quantum computing advances pose a real threat to current encryption standards, potentially leaving sensitive data vulnerable. By integrating Quantum.IQ’s platform, Redwood positions itself at the forefront of quantum-safe security solutions, which are increasingly critical for sectors handling classified or sensitive information. The acquisition aligns with Redwood’s strategy to leverage AI for chemistry R&D and now extends into cybersecurity, a growing market driven by the need for post-quantum cryptography.
For more details on the announcement, visit the full press release at https://ibn.fm/D0lb6. Redwood AI Corp. uses advanced artificial intelligence to accelerate chemistry R&D, with the aim of assisting in drug discovery and development, and furthering defense and safety solutions. The Company combines expertise in chemistry, AI, and manufacturing to streamline drug synthesis and scale-up. Redwood AI’s platform is designed to enable faster, more efficient development of new therapies and chemistry-driven applications. For more information, go to https://redwoodai.com/.
